| Autor: |
Pitcher III, John D., Witkin, Andre J., DeCroos, Francis Char, Ho, Allen C. |
| Předmět: |
|
| Zdroj: |
British Journal of Ophthalmology; Jun2015, Vol. 99 Issue 6, p848-852, 5p, 1 Color Photograph, 2 Charts, 1 Graph |
| Abstrakt: |
Aim To evaluate the role of intravitreal aflibercept injection as a treatment for eyes with chronic central serous chorioretinopathy (CSCR). Methods This prospective pilot study enrolled 12 patients with chronic CSCR who received a 6-month treatment regimen of intravitreal aflibercept. Patients were followed with monthly Early Treatment of Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) and spectral domain optical coherence tomography (SD-OCT) with enhanced depth imaging. Results All patients were men between 29 and 64 years (median 55). Subfoveal fluid was present on OCT for a median duration of 6 months (range 4-29 months) prior to treatment. Baseline BCVA ranged from 20/25 to 20/160 (median 20/50) with a mean of 62 (SD=13) ETDRS letters. No patients experienced serious ocular or systemic adverse events over the course of the study. Post-treatment BCVA ranged from 20/20 to 20/200 (median 20/40), with a mean of 64 (SD=16) ETDRS letters (p=0.56). At baseline, three patients (25%) had BCVA of ⩾20/40 versus seven patients (58%) at the conclusion of the study. Two patients gained at least 15 ETDRS letters and no patients lost more than 15 ETDRS letters. Six of 12 patients (50%) had complete resolution of subfoveal fluid. Mean central macular thickness decreased from 400 μm (SD=104 μm) to 306 μm (SD=94 μm) (p=0.03), and mean subfoveal fluid decreased from 159 μm (SD=93 μm) to 49 μm (SD=68 μm) ( p=0.02). Mean choroidal thickness decreased from 307 μm (SD=72 μm) to 263 μm (SD=63 μm) (p=0.0003). Conclusions Intravitreal aflibercept was well tolerated over a 6-month treatment course for chronic CSCR. No change was observed in visual acuity metrics. Anatomic trends may suggest some morphological activity, but larger controlled trials are needed. Trial registration number NCT01710332. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
